Capital Impact Advisors, LLC Vir Biotechnology, Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 23, 2023
SELL
$22.26 - $30.85 $132,736 - $183,958
-5,963 Reduced 45.19%
7,233 $168,000
Q3 2022

Nov 21, 2022
BUY
$18.26 - $31.1 $20,633 - $35,143
1,130 Added 9.37%
13,196 $360,000
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $63,574 - $88,964
-3,332 Reduced 21.64%
12,066 $307,000
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $326,283 - $616,073
15,398 New
15,398 $396,000

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $922M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email